Advertisement
UK markets close in 5 hours 45 minutes

  • FTSE 100

    8,178.89
    +31.86 (+0.39%)
     

  • FTSE 250

    20,097.86
    +13.07 (+0.07%)
     

  • AIM

    764.02
    +0.69 (+0.09%)
     

  • GBP/EUR

    1.1695
    -0.0018 (-0.15%)
     

  • GBP/USD

    1.2552
    -0.0010 (-0.08%)
     

  • Bitcoin GBP

    50,119.69
    -539.11 (-1.06%)
     

  • CMC Crypto 200

    1,290.97
    -48.10 (-3.59%)
     

  • S&P 500

    5,116.17
    +16.21 (+0.32%)
     

  • DOW

    38,386.09
    +146.43 (+0.38%)
     

  • CRUDE OIL

    82.92
    +0.29 (+0.35%)
     

  • GOLD FUTURES

    2,326.30
    -31.40 (-1.33%)
     

  • NIKKEI 225

    38,405.66
    +470.90 (+1.24%)
     

  • HANG SENG

    17,763.03
    +16.12 (+0.09%)
     

  • DAX

    18,042.52
    -75.80 (-0.42%)
     

  • CAC 40

    8,045.60
    -19.55 (-0.24%)
     
Stocks:

Trending tickers: Amazon, Tesla, Samsung, Mercedes-Benz, Whitbread

The latest investor updates on stocks that are trending on Tuesday

AbbVie says Shire rejected bid approach

Reuters - UK Focus

LONDON, June 20 (Reuters) - U.S. drugmaker AbbVie Inc (NYSE: ABBV - news) confirmed on Friday it had made a bid approach to Shire (Dusseldorf: S7E.DU - news) , which was rejected by the British group's board. It said talks were no longer ongoing.

AbbVie was responding to a Reuters story on Thursday which revealed the talks.

AbbVie's initial cash and share proposal in early May 2014 represented an indicative offer of 39.50 pounds per share for Shire (LSE: SHP.L - news) , and the third and latest cash and share proposal represented an indicative offer of 46.26 pounds, it said. (Reporting by Kate Holton, Editing by Li-mei Hoang)